Literature DB >> 31549206

Effects of oral florfenicol on intestinal structure, function and microbiota in mice.

Shiyu Yun1,2, Yurong Guo1, Lan Yang1, Xin Zhang2, Weiqi Shen1, Zhuo Wang1, Shuang Wen1, Dongdong Zhao1, Haiping Wu1, Jia Chen1, Yaogui Sun1, Zhibian Duan3.   

Abstract

Many kinds of antibiotics have effects on intestinal structure and function. In the current experimental study, we evaluate the effect of oral florfenicol on intestinal barrier in mice. Thirty adult male mice were randomly divided into two groups, the group none (N) and the group florfenicol (F), the mice in group F were orally administered florfenicol 100 mg/kg body weight (BW) for 7 days. At day 8, mice were euthanized and sampled for the analysis of alterations in genes and proteins from jejunum, jejunum morphology and microbiota analysis. Administration of florfenicol caused higher liver index (P < 0.05). In the jejunum, mucosa injury and villus rupture, compared with the group N, the villus length and V/C (villus length/crypt depth) in group F were marked decrease (P < 0.01). The transcription level of Muc2 and occludin in group F were significantly lower than those in group N (P < 0.01 or P < 0.05). The expression of APRIL, IL-17, IL-22, BAFF and sIgA on protein level were significantly down-regulated (P < 0.01 or P < 0.05), while the expression of IL-10, TGF-β, IL-6, IL-4 were significantly up-regulated (P < 0.01) in group F. The abundances of bacteria in Firmicutes and Lactobacillus decreased significantly (P < 0.01) in group F. Our results indicated that oral administration of florfenicol might have a negative impact on functions of intestinal mucosal barrier, immune system and the intestinal microbiota.

Entities:  

Keywords:  Florfenicol; Intestinal microbiota; Mouse; Mucosal barrier

Year:  2019        PMID: 31549206     DOI: 10.1007/s00203-019-01731-y

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  2 in total

1.  Chlamydia muridarum Alleviates Colitis via the IL-22/Occludin Signal Pathway.

Authors:  Xin Wang; Huai-Cai Zeng; Yan-Ru Huang; Qing-Zhi He
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

2.  Comparative Study on Synergistic Toxicity of Enrofloxacin Combined with Three Antibiotics on Proliferation of THLE-2 Cell.

Authors:  Yehui Luan; Kexin Chen; Junjie Zhao; Linli Cheng
Journal:  Antibiotics (Basel)       Date:  2022-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.